WallStreetZenWallStreetZen

NASDAQ: PTPI
Petros Pharmaceuticals Inc Stock Ownership - Who owns Petros Pharmaceuticals?

Insider buying vs selling

Have Petros Pharmaceuticals Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when PTPI insiders and whales buy or sell their stock.

PTPI Shareholders

What type of owners hold Petros Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
John D. Shulman81.48%5,703,544$2.40MInsider
Fady Boctor0.71%49,645$20.85kInsider
Vanguard Group Inc0.45%31,811$13.36kInstitution
Blackrock Inc0.24%16,510$6.93kInstitution
Joshua Silverman0.16%11,237$4.72kInsider
Geode Capital Management LLC0.15%10,502$4.41kInstitution
Bruce Bernstein0.12%8,346$3.51kInsider
Greg Bradley0.12%8,314$3.49kInsider
Wayne Remell Walker0.12%8,314$3.49kInsider
Tower Research Capital LLC Trc0.05%3,395$1.43kInstitution

1 of 3

PTPI vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PTPI0.92%82.74%
YCBD0.27%99.73%
SNOA0.88%20.71%
CPHI0.22%99.78%Net Buying
EVOK21.01%78.99%

Petros Pharmaceuticals Stock Ownership FAQ

Who owns Petros Pharmaceuticals?

Petros Pharmaceuticals (NASDAQ: PTPI) is owned by 0.92% institutional shareholders, 82.74% Petros Pharmaceuticals insiders, and 16.35% retail investors. John D. Shulman is the largest individual Petros Pharmaceuticals shareholder, owning 5.70M shares representing 81.48% of the company. John D. Shulman's Petros Pharmaceuticals shares are currently valued at $2.33M.

If you're new to stock investing, here's how to buy Petros Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.